Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c, provides guidance

Go back to Xeris Pharmaceuticals Inc. (XERS) Misses Q3 EPS by 2c, provides guidance
(NASDAQ: XERS) Delayed: 7.78 --0 (-0%)
Previous Close $7.78    52 Week High
Open $7.78    52 Week Low
Day High $7.78    P/E N/A 
Day Low $7.78    EPS
Volume 103